HEADER IMMUNE SYSTEM/INHIBITOR 06-JUN-18 6DN5 TITLE SPRY DOMAIN-CONTAINING SOCS BOX PROTEIN 2 COMPLEXED WITH WDINNN(BAL) TITLE 2 CYCLIC PEPTIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPRY DOMAIN-CONTAINING SOCS BOX PROTEIN 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SSB-2,GENE-RICH CLUSTER PROTEIN C9; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: WDINNN(BAL) CYCLIC PEPTIDE INHIBITOR; COMPND 8 CHAIN: B; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SPSB2, GRCC9, SSB2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: K12; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606 KEYWDS PROTEASOMAL DEGRADATION, NITRIC OXIDE, INHIBITOR, IMMUNE SYSTEM, KEYWDS 2 IMMUNE SYSTEM-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.H.P.LAW,T.T.CARADOC-DAVIES,R.S.NORTON REVDAT 2 08-JAN-20 6DN5 1 REMARK REVDAT 1 17-APR-19 6DN5 0 JRNL AUTH M.M.SADEK,N.BARLOW,E.W.W.LEUNG,B.J.WILLIAMS-NOONAN,B.K.YAP, JRNL AUTH 2 F.M.SHARIFF,T.T.CARADOC-DAVIES,S.E.NICHOLSON,D.K.CHALMERS, JRNL AUTH 3 P.E.THOMPSON,R.H.P.LAW,R.S.NORTON JRNL TITL A CYCLIC PEPTIDE INHIBITOR OF THE INOS-SPSB PROTEIN-PROTEIN JRNL TITL 2 INTERACTION AS A POTENTIAL ANTI-INFECTIVE AGENT. JRNL REF ACS CHEM. BIOL. V. 13 2930 2018 JRNL REFN ESSN 1554-8937 JRNL PMID 30226743 JRNL DOI 10.1021/ACSCHEMBIO.8B00561 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 9802 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.290 REMARK 3 FREE R VALUE TEST SET COUNT : 519 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.68 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.86 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2695 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1932 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2559 REMARK 3 BIN R VALUE (WORKING SET) : 0.1882 REMARK 3 BIN FREE R VALUE : 0.2950 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.05 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 136 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1543 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 10 REMARK 3 SOLVENT ATOMS : 103 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.39 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.46960 REMARK 3 B22 (A**2) : 1.36420 REMARK 3 B33 (A**2) : -4.83370 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.250 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.353 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.250 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.302 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.243 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.932 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.838 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1598 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2170 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 524 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 38 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 235 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1598 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 184 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1836 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.31 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.37 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 7.1256 77.5558 127.2820 REMARK 3 T TENSOR REMARK 3 T11: -0.0601 T22: 0.0272 REMARK 3 T33: -0.0750 T12: 0.0046 REMARK 3 T13: 0.0100 T23: 0.0025 REMARK 3 L TENSOR REMARK 3 L11: 1.1151 L22: 0.8628 REMARK 3 L33: 0.8482 L12: 0.2423 REMARK 3 L13: 0.4928 L23: 0.0794 REMARK 3 S TENSOR REMARK 3 S11: -0.0168 S12: -0.0361 S13: 0.0328 REMARK 3 S21: 0.0028 S22: 0.0141 S23: -0.0135 REMARK 3 S31: 0.0210 S32: -0.0205 S33: 0.0026 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6DN5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1000234584. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-APR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95370 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9853 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 42.240 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : 0.22500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.52 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.68700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HEPES PH 7.5, 20% PEG 4000, REMARK 280 10%ISOPROPANOL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 16.31000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.01000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.97500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.01000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 16.31000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.97500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE WDINNN(BAL) CYCLIC PEPTIDE INHIBITOR IS CYCLIC PEPTIDE, A REMARK 400 MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: WDINNN(BAL) CYCLIC PEPTIDE INHIBITOR REMARK 400 CHAIN: B REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 3 REMARK 465 HIS A 4 REMARK 465 HIS A 5 REMARK 465 HIS A 6 REMARK 465 HIS A 7 REMARK 465 HIS A 8 REMARK 465 HIS A 9 REMARK 465 SER A 10 REMARK 465 SER A 11 REMARK 465 GLY A 12 REMARK 465 VAL A 13 REMARK 465 ASP A 14 REMARK 465 LEU A 15 REMARK 465 GLY A 16 REMARK 465 THR A 17 REMARK 465 GLU A 18 REMARK 465 ASN A 19 REMARK 465 LEU A 20 REMARK 465 TYR A 21 REMARK 465 PHE A 22 REMARK 465 GLN A 23 REMARK 465 SER A 24 REMARK 465 MET A 25 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 27 CG CD OE1 OE2 REMARK 470 GLU A 98 CD OE1 OE2 REMARK 470 LYS A 145 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 52 57.48 -156.09 REMARK 500 ASP A 118 43.74 -89.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN B 6 BAL B 8 -119.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 496 DISTANCE = 6.11 ANGSTROMS REMARK 525 HOH A 497 DISTANCE = 6.54 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Ligand residues BAL B 8 through REMARK 800 TRP B 1 bound to ASN B 6 DBREF 6DN5 A 26 219 UNP Q99619 SPSB2_HUMAN 26 219 DBREF 6DN5 B 1 8 PDB 6DN5 6DN5 1 8 SEQADV 6DN5 MET A 3 UNP Q99619 INITIATING METHIONINE SEQADV 6DN5 HIS A 4 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 HIS A 5 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 HIS A 6 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 HIS A 7 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 HIS A 8 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 HIS A 9 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 SER A 10 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 SER A 11 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 GLY A 12 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 VAL A 13 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 ASP A 14 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 LEU A 15 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 GLY A 16 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 THR A 17 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 GLU A 18 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 ASN A 19 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 LEU A 20 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 TYR A 21 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 PHE A 22 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 GLN A 23 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 SER A 24 UNP Q99619 EXPRESSION TAG SEQADV 6DN5 MET A 25 UNP Q99619 EXPRESSION TAG SEQRES 1 A 217 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 217 GLY THR GLU ASN LEU TYR PHE GLN SER MET PRO GLU GLY SEQRES 3 A 217 LEU GLU GLU LEU LEU SER ALA PRO PRO PRO ASP LEU GLY SEQRES 4 A 217 ALA GLN ARG ARG HIS GLY TRP ASN PRO LYS ASP CYS SER SEQRES 5 A 217 GLU ASN ILE GLU VAL LYS GLU GLY GLY LEU TYR PHE GLU SEQRES 6 A 217 ARG ARG PRO VAL ALA GLN SER THR ASP GLY ALA ARG GLY SEQRES 7 A 217 LYS ARG GLY TYR SER ARG GLY LEU HIS ALA TRP GLU ILE SEQRES 8 A 217 SER TRP PRO LEU GLU GLN ARG GLY THR HIS ALA VAL VAL SEQRES 9 A 217 GLY VAL ALA THR ALA LEU ALA PRO LEU GLN THR ASP HIS SEQRES 10 A 217 TYR ALA ALA LEU LEU GLY SER ASN SER GLU SER TRP GLY SEQRES 11 A 217 TRP ASP ILE GLY ARG GLY LYS LEU TYR HIS GLN SER LYS SEQRES 12 A 217 GLY PRO GLY ALA PRO GLN TYR PRO ALA GLY THR GLN GLY SEQRES 13 A 217 GLU GLN LEU GLU VAL PRO GLU ARG LEU LEU VAL VAL LEU SEQRES 14 A 217 ASP MET GLU GLU GLY THR LEU GLY TYR ALA ILE GLY GLY SEQRES 15 A 217 THR TYR LEU GLY PRO ALA PHE ARG GLY LEU LYS GLY ARG SEQRES 16 A 217 THR LEU TYR PRO ALA VAL SER ALA VAL TRP GLY GLN CYS SEQRES 17 A 217 GLN VAL ARG ILE ARG TYR LEU GLY GLU SEQRES 1 B 7 TRP ASP ILE ASN ASN ASN BAL HET BAL B 8 5 HET SO4 A 301 5 HET SO4 A 302 5 HETNAM BAL BETA-ALANINE HETNAM SO4 SULFATE ION FORMUL 2 BAL C3 H7 N O2 FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 HOH *103(H2 O) HELIX 1 AA1 PRO A 26 ALA A 35 1 10 HELIX 2 AA2 ASP A 39 HIS A 46 1 8 HELIX 3 AA3 GLU A 61 GLY A 63 5 3 HELIX 4 AA4 PRO A 96 ARG A 100 5 5 SHEET 1 AA1 3 TRP A 48 CYS A 53 0 SHEET 2 AA1 3 THR A 75 GLY A 80 -1 O ARG A 79 N ASN A 49 SHEET 3 AA1 3 GLN A 116 THR A 117 -1 O THR A 117 N THR A 75 SHEET 1 AA2 6 TRP A 48 CYS A 53 0 SHEET 2 AA2 6 THR A 75 GLY A 80 -1 O ARG A 79 N ASN A 49 SHEET 3 AA2 6 TYR A 200 ALA A 205 -1 O ALA A 205 N ASP A 76 SHEET 4 AA2 6 VAL A 105 ALA A 109 -1 N GLY A 107 O ALA A 202 SHEET 5 AA2 6 SER A 130 ASP A 134 -1 O TRP A 131 N VAL A 108 SHEET 6 AA2 6 LEU A 140 TYR A 141 -1 O TYR A 141 N GLY A 132 SHEET 1 AA3 7 ILE A 57 LYS A 60 0 SHEET 2 AA3 7 TYR A 65 ARG A 68 -1 O TYR A 65 N LYS A 60 SHEET 3 AA3 7 GLN A 211 GLY A 218 -1 O VAL A 212 N PHE A 66 SHEET 4 AA3 7 LEU A 88 SER A 94 -1 N ALA A 90 O LEU A 217 SHEET 5 AA3 7 ARG A 166 ASP A 172 -1 O LEU A 171 N HIS A 89 SHEET 6 AA3 7 THR A 177 ILE A 182 -1 O GLY A 179 N VAL A 170 SHEET 7 AA3 7 THR A 185 PHE A 191 -1 O LEU A 187 N TYR A 180 LINK N TRP B 1 C BAL B 8 1555 1555 1.37 LINK C ASN B 6 N BAL B 8 1555 1555 1.38 CISPEP 1 TYR A 152 PRO A 153 0 -5.47 CISPEP 2 GLY A 218 GLU A 219 0 3.14 SITE 1 AC1 7 GLN A 151 GLY A 155 THR A 156 GLN A 157 SITE 2 AC1 7 LYS A 195 HOH A 404 HOH A 408 SITE 1 AC2 4 ARG A 45 HIS A 46 ARG A 69 ARG A 82 SITE 1 AC3 5 GLY A 184 ARG A 215 ASP B 2 ASN B 6 SITE 2 AC3 5 HOH B 104 CRYST1 32.620 65.950 110.020 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.030656 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015163 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009089 0.00000